Online Pharmacy US

PHILADELPHIA – The judge supervising the American Home Products National Settlement has ordered the Settlement Trust to pay Matrix benefits to two for mer diet drug users, but affirmed the trust’s denial of benefits to a third (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.).
Full story on lexis.com (Source: (more…)

PHILADELPHIA – An attorney representing the American Home Products National Settlement class told the judge supervising the litigation that all significant issues have been resolved and that most of the available funds have been disbursed in the settlement and litigation, paving the way for a fin al disbursement of common benefit fees (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, (more…)

PHILADELPHIA – A prominent diet drug plaintiff firm has filed objections to a common benefit fee application by a former associate, saying any such fee belongs to the firm (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products C orp., No. 99-20593, E.D. Pa.).
Full story on lexis.com (Source: LexisNexis® Mealey’s™ Fen-Phen/Redux (more…)

PHILADELPHIA – Calling it the “largest private-party settlement in the history of American litigation,” attorneys who administered the multidistrict litigation (MDL) over American Home Products’ diet drugs and negotiated the settlement valued at more than $5 billion on July 16 applied for a $403 million final award of common benefit fees (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. (more…)

PHILADELPHIA – Class counsel has sided with a matrix claimant who authorized his attorney to sign a Seventh Amendment opt-out form so it would be timely, saying Wyeth has no grounds now to ch allenge a form it has accepted for two years (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.).
Full story on lexis.com (more…)

PHILADELPHIA – The judge supervising the American Home Produ cts (AHP) National Settlement has made a final distribution of approximately $414 million in legal fees to the law firms that prosecuted the 10-year litigation and administered the resulting national settlement (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brow n, et al. v. American Home Products Corp., No. 99-20593, (more…)

PHILADELPHIA – The auditor who examines applications for common benefit fees in the diet drug multidistrict litigation reports that as of Ma rch 31, attorneys have spent more than 553,000 hours on common benefit work wi th a cumulative lodestar value of more than $156 million (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. (more…)